e-Drug3D 901 |
EPLERENONE
|
cas 107724-20-9 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
ATC code |
PK parameters F 69 PERCENT Solubility VERY SLIGHTLY SOLUBLE IN WATER |
Target TARGET MINERALOCORTICOID RECEPTOR PDB Ligand code = YNU (link to the list of PDB complexes) Download experimental 3D coordinates of YNU with added hydrogens |
DrugCentral Mineralocorticoid receptor UNIPROT P08235 NR3C2 |
Download SDF file | Pregn-4-ene-7,21-dicarboxylic acid, 9,11-epoxy-17-hydroxy-3-oxo-, .gamma.-lactone, 7-methyl ester, (7.alpha.,11.alpha.,17.alpha.)- Formula: Calculated chemical properties: MW 414.48 NB_atoms 30 XLogP 3.12 PSA 78.278 NB_HD 0 NB_HA 6 fsp3 0.79 Lipinski(0=no;1=yes) 1 |
FDA NDA 021437 (pdf not found) INN (EPLERENONE) INSPRA (UPJOHN) APPROVAL= AP YEAR= 2002 NDA 078482 (pdf not found) INN (EPLERENONE) EPLERENONE (CHARTWELL RX) APPROVAL= AP YEAR= 2008 NDA 078510 (pdf not found) INN (EPLERENONE) EPLERENONE (SANDOZ) APPROVAL= AP YEAR= 2008 NDA 203896 (pdf not found) INN (EPLERENONE) EPLERENONE (THINKRX) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 206922 (pdf not found) INN (EPLERENONE) EPLERENONE (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2017 NDA 208283 (pdf not found) INN (EPLERENONE) EPLERENONE (BRECKENRIDGE) APPROVAL= AP YEAR= 2018 NDA 212765 (pdf not found) INN (EPLERENONE) EPLERENONE (ADAPTIS) APPROVAL= AP YEAR= 2020 NDA 207842 (pdf not found) INN (EPLERENONE) EPLERENONE (WESTMINSTER PHARMS) APPROVAL= AP YEAR= 2021 NDA 214663 (pdf not found) INN (EPLERENONE) EPLERENONE (RISING) APPROVAL= AP YEAR= 2022 NDA 213812 (pdf not found) INN (EPLERENONE) EPLERENONE (ANNORA PHARMA) APPROVAL= AP YEAR= 2023 |
Other links: |